Opus Point Partners Management, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2019$235,000
-47.2%
12,927
+3.4%
0.42%
-35.4%
Q2 2019$445,000
+28.6%
12,503
+21.3%
0.66%
+40.3%
Q1 2019$346,000
-20.5%
10,305
-22.1%
0.47%
-51.0%
Q4 2018$435,000
-39.6%
13,223
+12.0%
0.96%
-44.3%
Q3 2018$720,000
+72.7%
11,803
+38.3%
1.72%
+90.2%
Q2 2018$417,000
-83.3%
8,532
-63.6%
0.90%
-81.5%
Q1 2018$2,490,000
-54.7%
23,431
-74.6%
4.88%
+2.7%
Q4 2017$5,498,000
+119.6%
92,070
-11.7%
4.76%
+111.7%
Q3 2017$2,504,000
+31.8%
104,328
+7.3%
2.25%
+29.1%
Q2 2017$1,900,000
-56.5%
97,199
-47.8%
1.74%
-46.3%
Q1 2017$4,372,000
+93.3%
186,287
+1.1%
3.24%
+80.1%
Q4 2016$2,262,000
-25.4%
184,328
+4.4%
1.80%
+5.9%
Q3 2016$3,034,000
+19.4%
176,611
-1.1%
1.70%
-30.7%
Q2 2016$2,540,000
-35.9%
178,531
-38.0%
2.45%
-19.9%
Q1 2016$3,962,000
-32.6%
288,158
-17.3%
3.06%
-21.1%
Q4 2015$5,874,000
+20.6%
348,583
-21.5%
3.88%
+44.4%
Q3 2015$4,869,000
+5.8%
444,258
+20.7%
2.69%
-26.3%
Q2 2015$4,603,000
+24.7%
367,963
+9.6%
3.65%
+17.8%
Q1 2015$3,692,000
+0.4%
335,650
+41.6%
3.09%
-14.9%
Q4 2014$3,676,000237,1093.64%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2016
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders